通过GPX4的m6A和m5C修饰,通过STING激活促进抗癌免疫力
Baoxiang Chen1,2,3,4, Yuntian Hong1,2,3, Xiang Zhai1,2,3
1Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
Cell death & disease
|December 8, 2023
概括
谷氨过氧化酶4 (GPX4) 在结肠癌中被上调,增强了免疫细胞的透. 它的修饰 (m6A和m5C) 激活cGAS-STING通路,为癌症免疫治疗提供了一个有前途的标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 癌症免疫疗法是一个快速发展的领域.
- 谷氨过氧化酶4 (GPX4) 对于防止脂质过氧化和维持细胞氧化还原平衡至关重要.
- 在结肠腺癌 (COAD) 免疫治疗中GPX4的作用尚未完全理解.
研究的目的:
- 研究GPX4在COAD中的表达和功能.
- 探索GPX4影响抗癌免疫力的机制.
- 评估GPX4在COAD中的预后和治疗价值.
主要方法:
- 全癌症分析GPX4表达及其与生存的相关性.
- 分析GPX4与免疫细胞透和免疫调节剂的关联.
- 调查GPX4修改 (m6A和m5C) 以及它们对cGAS-STING信号通路的影响.
主要成果:
- 在多种癌症,特别是COAD中,GPX4的调节显著上升,并且与更好的整体存活率有关.
- 上调的GPX4与增加的免疫细胞透和免疫调节器表达相关.
- GPX4修改 (m6A和m5C) 通过维持氧化还原稳态来激活cGAS-STING通路,增强抗COAD免疫力.
结论:
- 在COAD进展和免疫反应中,GPX4起着至关重要的作用.
- 通过cGAS-STING通路,GPX4修饰,特别是m6A和m5C,是通过cGAS-STING通路对抗癌免疫的关键调节者.
- 向GPX4修改为COAD免疫疗法提供了一个有希望的策略.
更多相关视频
07:21Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
2.1K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
